Keyword Analysis & Research: glargine insuline

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
glargine insuline	0.63	0.5	7072	16	17
glargine	1.98	0.3	7275	13	8
insuline	0.21	0.6	2967	40	8

Keyword	CPC	PCC	Volume	Score
glargine insulin	0.88	0.9	9388	36
glargine insuline	0.11	0.1	3910	17
glargine insulin pen	1.99	0.6	8852	26
glargine insulin for cats	0.34	0.1	9594	100
glargine insulin lantus	1.17	1	5018	72
glargine insulina	1.21	0.8	1788	75
glargine insulin peak	0.79	0.8	1060	70
glargine insulin walmart	1.07	0.1	4242	24
glargine insulin long acting	1.2	0.4	1678	19
glargine insulin price	0.91	0.7	2236	60
glargine insulin brand name	1.02	0.8	7157	97
glargine insulin side effects	0.72	0.1	9549	95
glargine insulin type	1.5	1	8117	68
glargine insulin dose cats	0.16	0.4	1213	64
insuline glargine lantus	1.38	0.4	1890	14

Insulin glargine Uses, Side Effects & Warnings - Drugs.com
drugs.com

https://www.drugs.com/mtm/insulin-glargine.html

Feb 18, 2022 · Insulin glargine is a long-acting insulin that starts to work several hours after injection and keeps working evenly for 24 hours. Insulin glargine is used to improve blood sugar control in people with diabetes mellitus. Toujeo is for use in adults with type 1 or type 2 diabetes.

DA: 62 PA: 3 MOZ Rank: 77

Glargine Insulin - StatPearls - NCBI Bookshelf
nih.gov

https://www.ncbi.nlm.nih.gov/books/NBK557756/

Apr 25, 2021 · Insulin glargine is a manmade version of human insulin that is FDA approved to treat adults and children with type 1 diabetes and adults with type 2 diabetes to improve and maintain glycemic control. Insulin glargine is a long-acting insulin injected once daily and provides a basal level of insulin throughout the day.

DA: 77 PA: 88 MOZ Rank: 74

Insulin glargine - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Insulin_glargine

Insulin glargine [GLAR geen], sold under the brand name Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes. It is typically the recommended long acting insulin in the United Kingdom. It is used once a day as an injection just under the skin. Effects generally begin an hour after use. Pregnancy category: AU: B3 Formula: C₂₆₇H₄₀₄N₇₂O₇₈S₆ Trade names: Lantus, Toujeo, Abasaglar, others

Pregnancy category: AU: B3
Formula: C₂₆₇H₄₀₄N₇₂O₇₈S₆
Trade names: Lantus, Toujeo, Abasaglar, others

DA: 20 PA: 2 MOZ Rank: 45

Insulin Glargine Dosage Guide + Max Dose, Adjustments
drugs.com

https://www.drugs.com/dosage/insulin-glargine.html

Feb 18, 2022 · -In a basal-bolus regimen, insulin glargine (basal insulin) provides approximately one-third to one-half of the total daily insulin requirement while pre-meal insulin (i.e., short-acting [bolus] insulin) should be used to satisfy the remainder of the daily insulin requirement.

DA: 14 PA: 100 MOZ Rank: 3

Insulin glargine - brand name list from Drugs.com
drugs.com

https://www.drugs.com/ingredient/insulin-glargine.html

Product(s) containing insulin glargine: insulin glargine systemic. Brand names: Lantus, Basaglar, Toujeo, Lantus SoloStar Drug class(es): insulin Insulin glargine systemic is used in the treatment of: Diabetes, Type 1; Diabetes, Type 2; Multi-ingredient medications containing insulin glargine: insulin glargine/lixisenatide systemic. Brand names: Soliqua Drug …

DA: 69 PA: 50 MOZ Rank: 32

Insulin Glargine (rDNA origin) Injection - MedlinePlus
medlineplus.gov

https://medlineplus.gov/druginfo/meds/a600027.html

Insulin glargine is a long-acting, manmade version of human insulin. Insulin glargine products work by replacing the insulin that is normally produced by the body and by helping move sugar from the blood into other body tissues where it is used for energy. It also stops the liver from producing more sugar.

DA: 43 PA: 3 MOZ Rank: 72

Insulin Glargine - FDA prescribing information, side …
drugs.com

https://www.drugs.com/pro/insulin-glargine.html

Mar 01, 2022 · Insulin Glargine (Insulin Glargine injection) is a sterile solution of Insulin Glargine for subcutaneous use. Insulin Glargine is a recombinant human insulin analog that is a long-acting, parenteral blood-glucose-lowering agent [see Clinical Pharmacology (12)]. Insulin Glargine has low aqueous solubility at neutral pH.

DA: 88 PA: 93 MOZ Rank: 67

Insulin glargine | C267H404N72O78S6 - PubChem
nih.gov

https://pubchem.ncbi.nlm.nih.gov/compound/Insulin-glargine

INSULIN GLARGINE is an active ingredient in 10 products including: 'INSULIN GLARGINE', 'LANTUS SOLOSTAR', and 'SOLIQUA 100/33'. National Drug Code (NDC) Directory 7.5 Clinical Trials 7.5.1 ClinicalTrials.gov ClinicalTrials.gov 7.5.2 EU Clinical Trials Register EU Clinical Trials Register 7.5.3 NIPH Clinical Trials Search of Japan

DA: 8 PA: 42 MOZ Rank: 83

Insulin glargine Side Effects: Common, Severe, Long Term
drugs.com

https://www.drugs.com/sfx/insulin-glargine-side-effects.html

Mar 13, 2022 · The median HbA1c values in the insulin glargine group ranged from 5.9% to 6.4% while the HbA1c values in the standard care group ranged from 6.2% to 6.6%. The incidence for all hypoglycemia was 58% and 26% in the …

DA: 94 PA: 64 MOZ Rank: 37

Efficacy and safety of insulin glargine 300 U/mL (Gla-300) …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488802/

Glargine 300 U/mL (Gla-300) is a second-generation basal insulin analog with a slow-release mechanism after subcutaneous injection that results in more even and prolonged pharmacokinetic and pharmacodynamic profiles compared with insulin glargine 100 U/mL (Gla-100). 15 The more gradual release of Gla-300 from the subcutaneous depot enables ...

DA: 89 PA: 23 MOZ Rank: 75